Lung cancer screening strategy for non-high-risk individuals: a narrative review

Lung cancer is the deadliest malignancy worldwide, accounting for almost 20% of all cancer deaths. Clinical trials, such as NLST and NELSON, have proved the survival benefit of lung cancer screening using low-dose computed tomography (LDCT), and most of the lung cancer screening guidelines recommend...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Fangqiu, Zhou, Yaodong, Zhang, Yang, Chen, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867778/
https://www.ncbi.nlm.nih.gov/pubmed/33569326
http://dx.doi.org/10.21037/tlcr-20-943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867778/
https://www.ncbi.nlm.nih.gov/pubmed/33569326
http://dx.doi.org/10.21037/tlcr-20-943

Ejemplares similares